220 related articles for article (PubMed ID: 34742270)
1. POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
Zhao XR; Fang H; Tang Y; Hu ZH; Jing H; Liang L; Yan XN; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Li N; Lu NN; Men K; Hu C; Zhang YH; Li YX; Wang SL
BMC Cancer; 2021 Nov; 21(1):1185. PubMed ID: 34742270
[TBL] [Abstract][Full Text] [Related]
2. Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial.
Kim YB; Byun HK; Kim DY; Ahn SJ; Lee HS; Park W; Kim SS; Kim JH; Lee KC; Lee IJ; Kim WT; Shin HS; Kim K; Shin KH; Nam CM; Suh CO
JAMA Oncol; 2022 Jan; 8(1):96-105. PubMed ID: 34695841
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial.
Zhang L; Mei X; Hu Z; Yu B; Zhang C; Li Y; Liu K; Ma X; Ma J; Chen X; Meng J; Shi W; Wang X; Mo M; Shao Z; Zhang Z; Yu X; Guo X; Yang Z
BMC Cancer; 2024 Jan; 24(1):49. PubMed ID: 38195438
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.
Chang JS; Park W; Kim YB; Lee IJ; Keum KC; Lee CG; Choi DH; Suh CO; Huh SJ
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):867-72. PubMed ID: 23747215
[TBL] [Abstract][Full Text] [Related]
5. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.
Hennequin C; Bossard N; Servagi-Vernat S; Maingon P; Dubois JB; Datchary J; Carrie C; Roullet B; Suchaud JP; Teissier E; Lucardi A; Gerard JP; Belot A; Iwaz J; Ecochard R; Romestaing P
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):860-6. PubMed ID: 23664327
[TBL] [Abstract][Full Text] [Related]
6. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
[TBL] [Abstract][Full Text] [Related]
7. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?
Freedman GM; Fowble BL; Nicolaou N; Sigurdson ER; Torosian MH; Boraas MC; Hoffman JP
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):805-14. PubMed ID: 10705000
[TBL] [Abstract][Full Text] [Related]
8. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
[TBL] [Abstract][Full Text] [Related]
9. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.
Qi WX; Cao L; Zheng S; Xu C; Cai R; Xu H; Cai G; Chen J
BMC Cancer; 2022 Dec; 22(1):1356. PubMed ID: 36575421
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.
Bazan JG; Healy E; Beyer S; Kuhn K; DiCostanzo D; Smith TL; Jhawar S; White JR
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1159-1171. PubMed ID: 32711036
[TBL] [Abstract][Full Text] [Related]
11. Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy.
Cho WK; Chang JS; Park SG; Kim N; Choi DH; Kim H; Kim YB; Park W; Suh CO
Breast; 2021 Oct; 59():37-43. PubMed ID: 34126377
[TBL] [Abstract][Full Text] [Related]
12. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.
Chung Y; Kim JW; Shin KH; Kim SS; Ahn SJ; Park W; Lee HS; Kim DW; Lee KC; Suh HS; Kim JH; Shin HS; Kim YB; Suh CO
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):419-26. PubMed ID: 25636764
[TBL] [Abstract][Full Text] [Related]
13. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
[TBL] [Abstract][Full Text] [Related]
14. Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
Wang X; Luo J; Jin K; Chen X; Zhang L; Meng J; Zhang X; Zhang Z; Shao Z; Bazan JG; Guo X; Yang Z; Yu X
Breast Cancer; 2020 Mar; 27(2):252-260. PubMed ID: 31696449
[TBL] [Abstract][Full Text] [Related]
15. Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy.
Lee TH; Chang JH; Jang BS; Kim JS; Kim TH; Park W; Kim YB; Kim SS; Han W; Lee HB; Shin KH
BMC Cancer; 2022 Nov; 22(1):1179. PubMed ID: 36384573
[TBL] [Abstract][Full Text] [Related]
16. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
Fowble B; Hanlon A; Freedman G; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Torosian M; Goldstein L
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):883-94. PubMed ID: 10863056
[TBL] [Abstract][Full Text] [Related]
17. Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center.
Misra S; Lee G; Maganti M; Koch CA
Breast Cancer Res Treat; 2020 Jul; 182(2):367-379. PubMed ID: 32474745
[TBL] [Abstract][Full Text] [Related]
18. Standard Tangential Radiation Fields Do Not Provide Incidental Coverage to the Internal Mammary Nodes.
Loganadane G; Kassick M; Kann BH; Young MR; Knowlton CA; Evans SB; Higgins SA; Belkacemi Y; Potenziani M; Saltmarsh N; Wilson LD; Moran MS
Pract Radiat Oncol; 2020; 10(1):21-28. PubMed ID: 31394256
[TBL] [Abstract][Full Text] [Related]
19. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
20. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy?
Kim KH; Noh JM; Kim YB; Chang JS; Keum KC; Huh SJ; Choi DH; Park W; Suh CO
Breast Cancer Res Treat; 2015 Aug; 152(3):589-99. PubMed ID: 26202053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
